Browsing Category
Healthcare Industry News
2470 posts
Thyrocare (NSE: THYROCARE) declares 2:1 bonus, Rs 7 dividend—too good to ignore?
Thyrocare posts 82% profit growth in Q2 FY26, declares 2:1 bonus issue and ₹7 interim dividend. Read how franchise and pathology growth powered results.
MyHealthChecked (AIM: MHC) stock drops 22.5% as Concepta sale to Boots UK turns firm into cash shell
MyHealthChecked’s shares plunge 22.5% after selling Concepta Diagnostics to Boots UK for £2.375m. Find out how this move changes its business model and outlook.
Johnson & Johnson to spin off DePuy Synthes, creating the world’s largest standalone orthopaedics company
Find out how Johnson & Johnson’s DePuy Synthes spin-off reshapes the $9 billion orthopaedics market and accelerates the company’s innovation focus.
Why did Sellas Life Sciences file to register 19.69m shares, and how could this affect SLS stock performance in 2025?
Sellas registers 19.69 M shares for resale after a warrant deal. Discover what it means for dilution, stock sentiment, and upcoming biotech catalysts.
Cosmos Health doubles down on Ethereum, expanding crypto treasury strategy under $300m facility
Find out how Cosmos Health is expanding its crypto-treasury strategy—boosting Ethereum holdings to $1.8 million under a $300 million financing facility.
Will Johnson & Johnson MedTech’s new CORE-VA registry finally bridge the real-world evidence gap in ventricular arrhythmia care?
Johnson & Johnson MedTech launches the CORE-VA registry to improve ventricular arrhythmia care with real-world data. Find out what it means for the sector!
Can Thermo Fisher’s new molecular test transform lung transplant care with faster rejection detection?
Discover how Thermo Fisher’s new AI-based MMDx Lung test improves early detection of lung transplant rejection and reshapes transplant diagnostics.
Inside the Monteris–Symphony alliance: Can AI-driven robotics make brain surgery safer and smarter?
Discover how Monteris Medical and Symphony Robotics are merging AI, robotics, and MRI precision to transform minimally invasive brain surgery.
VIVATRONIX and SpineX secure CDSCO approval for xStep device: Can India’s new neuromodulation era transform paralysis care?
India approves VIVATRONIX–SpineX xStep device for paralysis care—marking a major leap for noninvasive neuromodulation and India’s medtech future.
Medtronic (NYSE: MDT) launches Embrace Gynecology study — will Hugo RAS redefine robotic hysterectomies in the U.S.?
Medtronic’s Embrace Gynecology trial tests Hugo RAS in hysterectomies—can it challenge da Vinci’s dominance and reshape women’s robotic surgery?